Ticker ALGN – Align – sales, description, marketcap – Tickerday.com

ALGN

Align

–

Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;

Marketcap: 25.93B; Volume: 96.33K; AvgVol 3m: 714.86K; Beta: 1.85;

Cost estimate:

P/E: 14.88; EPS: 21.51; EPS growth quarter/prev quarter: -128.20%;

EPS growth this year: 12.40%; EPS growth past 5 years: 25.50%;

EPS ttm: 21.51;

P/S: 11.63; P/B: 8.75; P/Cashflow: 62.11; P/FCF: 67.38;

Sales: 2.16B; Sales growth quarter/prev quarter: -41.40%; Sales growth past 5 years: 25.90%;

Profitability:

Gross Margin: 70.70%; Profit Margin: 78.70%; Operating Margin: 12.70%;

ROA – return on assets: 53.00%; ROE – return on equity: 81.50%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.60%; Insider Transactions:-23.56%;

Institutional Ownership: 89.30%; Institutional Transactions: 0.68%;

Data update: 07.10.2020.